Malaysian-Made ProDetect® Rapid Test-Kit Scores 100% Accuracy in International Assessment

As the Omicron variant takes hold in Malaysia, the availability of high accuracy Antigen Test Kits is increasingly vital in the drive to identify infection early on and prevent further spread in the community. The ProDetect® COVID-19 Antigen Rapid Test, manufactured in Malaysia by Medical Innovation Ventures Sdn Bhd (Mediven®), recently obtained a 100% accuracy score in a well-regarded international third-party External Quality Assessment Programme (EQAP) conducted by the European Society for EXTERNAL QUALITY ASSESSMENT (EsFEQA).

Dr Lim Li Sze, Operations Director of Mediven®, said “The COVID-19 rapid test serves as a valuable initial screening tool. As confirmed in the EQAP, our ProDetect® test kit appears to retain its quality and consistency in providing a high level of accuracy. This is crucial for early detection, isolation, and treatment of those infected and to prevent the spread of COVID-19 infection.” The ProDetect® Test-Kit gives results within 15-20 minutes and is able to screen for all variants of concern (VOC), including delta and omicron.

A total of 122 clinics and hospitals from 13 states and federal territories across West and East Malaysia who use the ProDetect® brand took part in the EQAP.

Mr Ariff Ismail, Executive Director of Mediven® said, “Our achievement in the EQAP assessment serves as a testament, in recognition of the dedication and ingenuity of the team at Mediven®, as we strive to deliver cutting-edge diagnostics technology from bench side to bed side.”

Gerard Monteiro of OMESTI Healthcare, one of Mediven®’s partners in the sales and distribution of the ProDetect® Test kits, added, “This prestigious recognition is an important validation of the quality and accuracy of the Mediven® ProDetect® kits. It will give our customers even greater reassurance and peace of mind when using these kits.”

The company recently partnered with MyDocLab™ to launch a healthcare app which enables schools, corporates and individuals to manage their employee and self-health status in an effective and simple manner and allows easy reporting for international border crossing.

About Mediven® Medical Innovation Ventures Sdn. Bhd. (Mediven®) is a medical diagnostic company which develops, manufactures, and markets advanced high quality clinical diagnostic molecular and rapid tests. With a vision to be a leading provider of personalised healthcare through innovative diagnostics, Mediven® provides solutions for screening of a variety of infectious diseases including dengue, chikungunya, zika, malaria, influenza, tuberculosis and many more. 

Mediven® production facilities comply with ISO 13485:2016 and its products are compliant with EU relevant legislation on safety, health & environmental requirements, allowing the sales of products under the CE Mark within the European Economic Area. Mediven® also holds a medical device production licence from the Malaysian Medical Authority (MDA) and the Good Distribution Practice for Medical Devices (GDPMD) certification.